Navigation Links
Mesa Labs Reports Higher First Quarter Earnings
Date:8/11/2009

LAKEWOOD, Colo., Aug. 11 /PRNewswire-FirstCall/ -- Mesa Laboratories, Inc. (Nasdaq: MLAB) today reported higher earnings for the fiscal first quarter ended June 30, 2009.

Highlights:

  • First quarter revenues decreased less than 2% from last fiscal year
  • Operating income increased 5% over last fiscal year
  • Medical Product sales increase 12%
  • Raven Biological Indicator Product sales increase 16%

For the first quarter of fiscal 2010, net sales decreased two percent to $4,977,000 from $5,054,000 in the same quarter last year. Net income for the quarter increased one percent to $1,026,000 or $.31 per diluted share of common stock compared to $1,016,000 or $.31 per diluted share of common stock last year.

"During a time when many other companies are really struggling, we are pleased to report increased profits compared to last year," said John J. Sullivan, President and Chief Executive Officer. "This first quarter of our new fiscal year started off well and, while revenue decreased slightly compared to last year, we actually posted five percent higher orders during the quarter than the comparable period last year. Both orders and sales for our Medical and Raven lines continue to grow well, while the DataTrace line is still struggling. However, after seeing large sequential quarter-to-quarter decreases in DataTrace orders, we have recently seen a stabilization of this business, albeit at a lower level than this time last year. We are hopeful for a recovery in the DataTrace business going forward, as our customer's focus on increasing their capital equipment spending. We are also pleased with our profits this quarter. As always, we continue to closel
'/>"/>

SOURCE Mesa Laboratories, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Physician Owned and Operated Hospitals Get Top Rankings From Consumer Reports, but They Remain on the Healthcare Reform Chopping Block
2. Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments
3. Winner Medical Reports Third Quarter Fiscal 2009 Results
4. Vion Pharmaceuticals Reports 2009 Second Quarter And Six-Month Results
5. DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results
6. Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results
7. Cardiac Science Reports Q2 Revenue; Resumes AED Shipments
8. PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results
9. Milestone Scientific Reports 44% Increase in Revenues in First Six Months of 2009 Compared to Prior Year
10. Pharmasset Reports Fiscal Third Quarter 2009 Financial Results
11. Star Scientific Files Second Quarter Financial Results; Rock Creek Pharmaceuticals Reports Early Promising Results in Studies Assessing Safety and Viability of Active Components for a Non-Nicotine Nutraceutical (CigRx(TM))
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2015)... 2015 Insuranceautoquote.info has released a new ... insurance quotes . , Clients can review important ... The online environment provides important advantages for clients who ... Drivers who do not have coverage for their vehicles ... season, day or hour. Many agencies offer important discounts ...
(Date:4/18/2015)... 18, 2015 Thousand of DePuy Pinnacle ... of individuals who were allegedly harmed by a metal-on-metal ... forward in the U.S. District Court, Northern District of ... Court has amended an earlier Case Management Order to ... things, the new amendment permits the claims of up ...
(Date:4/18/2015)... 2015 Aureus Medical Group (web: ... physical therapy jobs, has announced that it will ... Physical Therapy Association Annual Conference to be held ... Greenville, SC. , The SCAPTA Annual Conference ... products and services. , Representatives from Aureus ...
(Date:4/17/2015)... Heritage Woods of McLeansboro, a Gardant affordable ... Celebration on April 20 with a day full of ... and soul. , The community, which is located at ... of all incomes, including those on Medicaid, who need ... Week is observed every April and highlights the communities ...
(Date:4/17/2015)... 2015 Riviera Magazine has ... of the Gallery of Cosmetic Surgery in Newport ... experts. The publication focused on his expertise in ... fat grafting, eyelid surgery, laser resurfacing and rhinoplasty. , ... has resulted in thousands of satisfied patients across ...
Breaking Medicine News(10 mins):Health News:Clients Can Review Car Insurance Quotes Online To Find Low Cost Offers! 2Health News:DePuy Pinnacle Hip Lawsuits: Federal Litigation Amends Case Management Order to Allow for Joinder of Unrelated Claims 2Health News:DePuy Pinnacle Hip Lawsuits: Federal Litigation Amends Case Management Order to Allow for Joinder of Unrelated Claims 3Health News:Healthcare Staffing Leader, Aureus Medical Group, to Exhibit at the South Carolina Physical Therapy Association Annual Conference 2Health News:Heritage Woods of McLeansboro Affordable Assisted Living to Celebrate Supportive Living Week 2Health News:Heritage Woods of McLeansboro Affordable Assisted Living to Celebrate Supportive Living Week 3Health News:Orange County Facial Plastic Surgeon Featured in Premier Magazine Focused on Beauty 2Health News:Orange County Facial Plastic Surgeon Featured in Premier Magazine Focused on Beauty 3
... cerebrovascular disease , MONDAY, Dec. 10 (HealthDay News) -- ... for mild cognitive impairment, says a study by researchers ... City. , Mild cognitive impairment, which causes learning and ... years, particularly as a means of identifying the early ...
... team of researchers from the University of Pennsylvania School ... in the immune system process that fights infection yet, ... tissue., The Penn team, led by Christopher Hunter, chair ... identified the pathways that lead to the production of ...
... Although psychiatrists are among the least religious physicians, they ... and spiritual dimensions of their patients, according to survey ... Journal of Psychiatry. , Ever since Freud described religious ... been tension and at times hostility between religion and ...
... problems with Prilosec and Nexium , , MONDAY, Dec. ... of the popular heartburn drugs Prilosec and Nexium found ... Monday. , The announcement followed a three-month safety review ... preliminary studies. But detailed data from both studies, plus ...
... Dec. 10 JPMorgan,s Annual,Healthcare Conference, which celebrates ... 7-10 at the Westin St. Francis Hotel in ... largest, will feature,presentations from approximately 300 companies, both ... This year,s event will include,panel discussions with leading ...
... mg, * 53% of Patients Treated with 90 mg Dose ... in the Risk of Death ... Compared to Non-responders, ATLANTA, Dec. 10 Pharmion ... data,from the Phase 1/2 study investigating the combined use of MGCD0103, a,novel, ...
Cached Medicine News:Health News:Hypertension Linked to Risk of Mild Cognitive Impairment 2Health News:Researchers led by Penn vet uncover the delicate protein balance behind the immune system response 2Health News:Psychiatrists: Least religious but most interested in patients' religion 2Health News:Psychiatrists: Least religious but most interested in patients' religion 3Health News:Psychiatrists: Least religious but most interested in patients' religion 4Health News:FDA Confirms No Heart Risk From Heartburn Drugs 2Health News:FDA Confirms No Heart Risk From Heartburn Drugs 3Health News:JPMorgan's 26th Annual Healthcare Conference Media Advisory 2Health News:Pharmion and MethylGene Present Favorable Clinical Data From Combination MGCD0103/Vidaza(R) Study in Myelodysplastic Syndromes and Acute Myelogenous Leukemia at The 49th American Society of Hematology (ASH) Meeting 2Health News:Pharmion and MethylGene Present Favorable Clinical Data From Combination MGCD0103/Vidaza(R) Study in Myelodysplastic Syndromes and Acute Myelogenous Leukemia at The 49th American Society of Hematology (ASH) Meeting 3Health News:Pharmion and MethylGene Present Favorable Clinical Data From Combination MGCD0103/Vidaza(R) Study in Myelodysplastic Syndromes and Acute Myelogenous Leukemia at The 49th American Society of Hematology (ASH) Meeting 4Health News:Pharmion and MethylGene Present Favorable Clinical Data From Combination MGCD0103/Vidaza(R) Study in Myelodysplastic Syndromes and Acute Myelogenous Leukemia at The 49th American Society of Hematology (ASH) Meeting 5Health News:Pharmion and MethylGene Present Favorable Clinical Data From Combination MGCD0103/Vidaza(R) Study in Myelodysplastic Syndromes and Acute Myelogenous Leukemia at The 49th American Society of Hematology (ASH) Meeting 6Health News:Pharmion and MethylGene Present Favorable Clinical Data From Combination MGCD0103/Vidaza(R) Study in Myelodysplastic Syndromes and Acute Myelogenous Leukemia at The 49th American Society of Hematology (ASH) Meeting 7
(Date:4/17/2015)... , Apr. 17, 2015 Research and Markets ... the "Medical Oxygen Systems - Global Strategic Business ... report analyzes the worldwide markets for Medical Oxygen Systems ... Liquid Oxygen Systems, Oxygen Cylinders & Regulators, and Oxygen ... the US, Canada , ...
(Date:4/17/2015)... Steven Rash , the CEO of Algae International Group, ... Seed & Oil Company, presented the Company,s latest developments ... York City.  Mr. Rash,s presentation featured the Company,s Product ... Company has recently announced the Dube Hemp Energy ... the EpiVape , and Hempster Clothing .  ...
(Date:4/17/2015)... and Markets ( http://www.researchandmarkets.com/research/7qs3dw/corporate ) has announced ... in 2014 - a Perspective of Diabetes Patient Groups ... This independent study, funded by the author, represents ... in diabetes on the corporate reputation of 14 individual ... whole) in 2014. The results from the respondent diabetes ...
Breaking Medicine Technology:Medical Oxygen Systems - 2015 Global Strategic Business Report Featuring Leading Players, Caire, Invacare & Philips Respironics 2American Seed & Oil Company Benchmarks its Consumer Product Development Strategy Against Proctor & Gamble 2American Seed & Oil Company Benchmarks its Consumer Product Development Strategy Against Proctor & Gamble 3Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 2Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 3Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 4Perspective of Diabetes Patient Groups on the Corporate Reputation of Pharma in 2014: 130 patient groups with an interest in diabetes from 34 countries 5
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: